Saturday , August 24 2019
Home / The Angry Bear / Preventive Drugs in the Last Year of Life

Preventive Drugs in the Last Year of Life

Summary:
I had thought these types of treatment had gone by the wayside in treatment during the last year of life. According to an Medscape article they have not. “‘Physicians should carefully consider whether the prescribed drugs are likely to achieve their benefit within the patient’s remaining lifetime,’ the authors concluded. The study included 151,201 patients ages 65 years and older who died in Sweden at a mean age of 81.3 years from 2007 to 2013. ‘The use and cost of preventive drugs during the last 12 months of life were the main study outcomes.’ The drugs of ‘questionable benefit’ assessed in the current study included antidiabetic drugs, antihypertensives, statins, and bisphosphonates medications for the treatment of chronic anemia and vitamin and

Topics:
run75441 considers the following as important: , , ,

This could be interesting, too:

run75441 writes Denmark Offers to Buy the US

run75441 writes Sunday Morning Commentary

run75441 writes Science Backed Home Healthcare Remedies

run75441 writes Traffic Jam in Shenzhen, China

I had thought these types of treatment had gone by the wayside in treatment during the last year of life. According to an Medscape article they have not.

“‘Physicians should carefully consider whether the prescribed drugs are likely to achieve their benefit within the patient’s remaining lifetime,’ the authors concluded. The study included 151,201 patients ages 65 years and older who died in Sweden at a mean age of 81.3 years from 2007 to 2013. ‘The use and cost of preventive drugs during the last 12 months of life were the main study outcomes.’ The drugs of ‘questionable benefit’ assessed in the current study included antidiabetic drugs, antihypertensives, statins, and bisphosphonates medications for the treatment of chronic anemia and vitamin and mineral supplements.’

Receipt of these long term preventative drugs added 20% to the cost of treatment during the final year of life. ‘The median drug cost during the last year of life was $1,482 (interquartile range $700-$2,896).'”

About run75441

Leave a Reply

Your email address will not be published. Required fields are marked *